✦ LIBER ✦

Treatment of acute lymphoblastic leukemia in adults

✍ Scribed by Prof. Tiziano Barbui; Renato Bassan; Teodoro Chisesi; Raffaele Battista; Sergio Cortelazzo; Francesco Rodeghiero; Giovanni Capnist; Anna D'emilio; Piera Viero; Enrico Dini

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 276 KB
Volume: 3
Category: Article
ISSN: 0278-0232
DOI: 10.1002/hon.2900030107

No coin nor oath required. For personal study only.

✦ Synopsis

Thirty-seven adult patients with acute lymphoblastic leukemia were treated with a protocol called HEAV'D including Adriamycin, Vincristine, L-Asparaginase, Cyclophosphamide and Dexamethasone. The complete remission rate was 70 per cent. The median duration of remission was more than 30 months. Patients with initial leukocyte count below 20 000/mmc experienced a longer remission (median not reached) than patients with a leukocyte count above 20 000/mmc (median 10 months).

📜 SIMILAR VOLUMES

Successful combination treatment of clof

Successful combination treatment of clofarabine, cytarabine, and gemtuzumab-ozogamicin in adult refractory B-acute lymphoblastic leukemia

✍ Cristina Papayannidis; Enrico Derenzini; Ilaria Iacobucci; Antonio Curti; Stefan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

Ultrastructural cytochemical prospective

Ultrastructural cytochemical prospective study of adult acute lymphoblastic leukemia: Detection of peroxidase activity in patients failing to respond to treatment

✍ Josy Reiffers; Vivianne Darmendrail; Jacky Larrue; Isabelle Villenave; Philippe 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB 👁 2 views

Ultrastructural cytochemical studies revealed peroxidase activity in five of 25 adult patients with apparent null lymphoblastic leukemia (ALL) in whom the peroxidase reaction studied with light microcopy was negative. None of these 5 patients responded to a chemotherapy regimen used for adult ALL. T

Randomized study comparing 4′-epi-doxoru

Randomized study comparing 4′-epi-doxorubicin (Epirubicin) versus doxorubicin as a part of induction treatment in adult acute lymphoblastic leukemia

✍ Manisha Bhutani; Lalit Kumar; Amish Vora; Narendra Bhardwaj; Ashutosh Kumar Path 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 1 views

Treatment outcome in young adults and ch

Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden : A comparison between a pediatric protocol and an adult protocol

✍ Helene Hallböök; Göran Gustafsson; Bengt Smedmyr; Stefan Söderhäll; Mats Heyman; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 1 views

Minimal residual disease (MRD) monitorin

Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients

✍ Tomomi Toubai; Junji Tanaka; Shuichi Ota; Takashi Fukuhara; Satoshi Hashino; Tak 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 3 views

Lineage specific treatment of adult pati

Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine : Cancer and Leukemia Group B Study 9311

✍ Ted P. Szatrowski; Richard K. Dodge; Carol Reynolds; Carol A. Westbrook; Stanley 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

## Background: Anti-b4-blocked ricin is an immunotoxin comprised of an anti-cd19 murine monoclonal antibody (b4) conjugated to blocked ricin, which has cytotoxic activity in patients with lymphoid malignancies. ## Methods: Adults with untreated acute lymphoblastic leukemia (all) were treated with